Stenosis of Arteria-Venous Fistula in Maintenance Hemodialysis Patients: Early Intervention Trial (SAVEIT)
Randomized Controlled Trial to Compare Therapeutic Effect of Digital Subtraction Angiography(DSA),Ultrasound Guided Balloon Dilatation and Surgical Reconstruction in Arteria-venous Fistula(AVF) Stenosis in Maintenance Hemodialysis Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Eligibility Criteria:
- Patients with long-term maintenance hemodialysis with AVF as the vascular access;
- Positive clinical examination signs of AVF stenosis (not all required) : (1) the visual examination: edema, prolonged bleeding time, hematoma, aneurysm or constriction of the fistula .(2) the palpation examination: a narrowing of the outflow vein or aneurysm formation. (3) the auscultation examination: high pitch and/or discontinuous murmur.
- Doppler ultrasound /DSA/magnetic resonance angiography show the diameter of AVF fistula is >50% narrow than the adjacent segment of the fistula lumen.
- Blood flow of the AVF is <500ml/min or monthly declines of the blood flow>25%.
- Patient signed the informed consent.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Changlin Mei, MD
- Phone Number: 0086 21 81885411
- Email: chlmei1954@126.com
Study Locations
-
-
-
Shanghai, China, 200003
- Shanghai Changzheng Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with long-term maintenance hemodialysis with AVF as the vascular access;
- Positive clinical examination signs of AVF stenosis (not all required) : (1) the visual examination: edema, prolonged bleeding time, hematoma, aneurysm or constriction of the fistula .(2) the palpation examination: a narrowing of the outflow vein or aneurysm formation. (3) the auscultation examination: high pitch and/or discontinuous murmur;
- Doppler ultrasound /DSA/MRA show the diameter of AVF fistula is >50% narrow than the adjacent segment of the fistula lumen;
- Blood flow of the AVF is <500ml/min or monthly declines of the blood flow>25%;
- Patient signed the informed consent.
Exclusion Criteria:
- allergic to the iodine contrast or gadolinium contrast agent;
- local infection;
- the presence of severe coagulation dysfunction (or long-term history of taking warfarin or ticlopidine);
- the presence of severe artery steal syndrome;
- stenosis of immature fistula or fistula <2 month after vascular anastomosis;
- severe central venous stenosis;
- discontinue hemodialysis treatment (such as to transfer to peritoneal dialysis or kidney transplant);
- severe cardiac dysfunction (New York Heart Association cardiac functional classification III or worse), unstable angina pectoris, myocardial infarction, severe left ventricular hypertrophy, or severe vascular embolic disease;
- participated in other clinical trials within 12 weeks;
- alcohol and/or drug abusers, mental disorders;
- patients not suitable as the subjects of this trial under the consideration of researchers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group 1
DSA guided percutaneous balloon dilatation to expand the stenosis of arteriovenous fistula
|
Under the guidance of DSA, balloon is introduced into the stenosis area, proper pressure is given to achieve balloon dilatation to expand the narrow AVF lumen.
|
|
Experimental: Group 2
Ultrasound guided percutaneous balloon dilatation to expand the stenosis of arteriovenous fistula
|
Under the guidance of ultrasound, balloon is introduced into the stenosis area, proper pressure is given to achieve balloon dilatation to expand the narrow AVF lumen.
|
|
Experimental: Group 3
Surgical reconstruction of the stenosis to reconstruction the lumen of arteriovenous fistula
|
Direct surgery to reconstruction the AVF lumen.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the patency rate of the AVF after intervention
Time Frame: 24 month
|
the patency rate including the primary and the secondary patency rate
|
24 month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The success rate of AVF stenosis interventions
Time Frame: 24 month
|
Described as %.
|
24 month
|
|
The recurrence rate of AVF stenosis interventions
Time Frame: 24 month
|
Described as %.
|
24 month
|
|
The side effects of AVF stenosis interventions
Time Frame: 24 month
|
Described as %.Side effects including bleeding, infection, thrombosis, artery steal syndrome, heart failure, inadequate dialysis, etc.
|
24 month
|
|
The cost-effectiveness analysis of AVF stenosis interventions
Time Frame: 24 month
|
Described as $.
|
24 month
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CZHKI-HDVA-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.